Catalyst Wire Dossier Catalyst Wire Dossier

Palonosetron Hospira

palonosetron hydrochloride · Pfizer Europe MA EEIG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Palonosetron Hospira, covering 2022-04-08 to 2022-04-08. Get the full timeline:

Most recent: EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG

See pricing